RLAY
Relay Therapeutics, Inc. - Common Stock (RLAY)
$59
About Relay Therapeutics, Inc. - Common Stock (RLAY)
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Details
Daily high
$3.64
Daily low
$3.52
Price at open
$3.57
52 Week High
$10.72
52 Week Low
$1.78
Market cap
608.6M
Dividend yield
0.00%
Volume
1.3M
Avg. volume
1.6M
P/E ratio
-1.59
Relay Therapeutics, Inc. - Common Stock News
Details
Daily high
$3.64
Daily low
$3.52
Price at open
$3.57
52 Week High
$10.72
52 Week Low
$1.78
Market cap
608.6M
Dividend yield
0.00%
Volume
1.3M
Avg. volume
1.6M
P/E ratio
-1.59